Parathyroid hormone formulation
US5496801A · kind A · utility
42Cited by
10References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 1993 |
| Grant date | Mar 5, 1996 |
| Priority date | — |
| Expiry date | Dec 23, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are preparations containing parathyroid hormone that has been stablized with an excipient and buffering agent. Preferred preparations incorporate human PTH(1-84), mannitol as excipient and citrate as buffering agent, and are incorporated in vials as a freeze-dried powder for reconstitution to treat osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.